RV

Renuka Vijay Giri

Director Director DIN 08484885
DIN 08484885 First appointment Jun 2019 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 0 active board seats
Past companies 1 historical roles
Total affiliations 1 Since Jun 2019
Shareholding value Locked Premium profile

About Renuka Vijay Giri

Data last updated:

Renuka Vijay Giri has 7 years in corporate governance. Formerly with 1 company, such as Delmax Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 08484885
Primary Designation Director
First Appointment 17 Jun 2019
Oldest Company Age Not Provided

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedStatus
Director17 Jun 20192019Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Delmax Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Renuka Vijay Giri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renuka Vijay Giri

Renuka Vijay Giri has 7 years in corporate governance. Formerly with 1 company, such as Delmax Pharmaceuticals Private Limited. Engaged in General Business. Contributes to corporate operations.

Renuka Vijay Giri is associated with 0 companies as a director.

Renuka Vijay Giri has expertise in General Business.

Renuka Vijay Giri has 7 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available